Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
5.78
-0.28 (-4.54%)
Sep 11, 2026, 4:08 PM HKT
Jacobio Pharmaceuticals Group Employees
Jacobio Pharmaceuticals Group had 207 employees as of June 30, 2026. The number of employees increased by 140 or 208.96% since the number was reported on December 31, 2025.
Employees
207
Change
140
Growth
208.96%
Revenue / Employee
4.12M HKD
Profits / Employee
2.86M HKD
Market Cap
4.53B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 207 | 140 | 208.96% |
| Dec 31, 2025 | 67 | 5 | 8.06% |
| Dec 31, 2024 | 62 | -239 | -79.40% |
| Dec 31, 2023 | 301 | -2 | -0.66% |
| Dec 31, 2022 | 303 | 41 | 15.65% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsJacobio Pharmaceuticals Group News
- 16 days ago - Jacobio Turns A Profit In Q2 On Higher Revenue - Nasdaq
- 18 days ago - Jacobio Pharmaceuticals Group Earnings release: H1 2026 - Filings
- 6 months ago - Jacobio Pharmaceuticals Group Earnings release: H2 2025 - Filings
- 6 months ago - Jacobio Pharmaceuticals Group Annual report: H2 2025 - Filings
- 8 months ago - Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73 - PRNewsWire
- 11 months ago - Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline - PRNewsWire
- 1 year ago - Jacobio Pharma Announces 2025 Interim Results - PRNewsWire
- 1 year ago - Jacobio's IND for Phase I/II Clinical Trial of BET Inhibitor JAB-8263 in Autoimmune Diseases has been Accepted - PRNewsWire